Shanghai, China
HighLight Capital (HLC) is a private investment firm dedicated to creating long-term values through promoting technology innovations. Empowered by our deep knowledge in chemical, biological and material sciences, and leveraging our proprietary industry research and comprehensive enablement services, we strive to invest in companies that boost manufacturing efficiency and improve human wellness. Since inception HLC has invested in over 120 leading companies, including Mindray, Wuxi Apptec, Tigermed, Pharmaron, Hongene, Zentalis, Singular, Nayuki, Etana and more. HLC currently manages over US$2.6 billion, with operations across key Asian growth hubs such as Shanghai, Beijing, Hong Kong and Tokyo.
51
Total Investments
44
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Finance, Health Care
Funding Stage
Series B
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About HighLight Capital
Recent Investments (51)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | May 2025 | |
| Series A | •••••• | Mar 2024 | |
| Seed Round | •••••• | Nov 2023 | |
| Series C | •••••• | Jul 2023 | |
| Series A | •••••• | May 2023 | |
•••• ••••
|
Series A | •••••• | May 2023 |
|
•••• ••••
|
Series C | •••••• | Apr 2023 |
|
•••• ••••
|
Seed Round | •••••• | Mar 2023 |
|
•••• ••••
|
Debt Financing | •••••• | Mar 2023 |
|
•••• ••••
|
Series C | •••••• | Jan 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
